Non-canonical Notch signaling activates IL-6/JAK/STAT signaling in breast tumor cells and is controlled by p53 and IKKα/IKKβ

[1]  Kimberly Foreman,et al.  Notch-1 and Notch-4 Biomarker Expression in Triple-Negative Breast Cancer , 2012, International journal of surgical pathology.

[2]  John J Dunn,et al.  Distinct p53 genomic binding patterns in normal and cancer-derived human cells , 2011, Cell cycle.

[3]  Pauliina Kronqvist,et al.  Hypo- and hyperactivated Notch signaling induce a glycolytic switch through distinct mechanisms , 2011, Proceedings of the National Academy of Sciences.

[4]  A. Chinnaiyan,et al.  Functionally Recurrent Rearrangements of the MAST Kinase and Notch Gene Families in Breast Cancer , 2011, Nature Medicine.

[5]  T. Palaga,et al.  Direct regulation of interleukin-6 expression by Notch signaling in macrophages , 2011, Cellular and Molecular Immunology.

[6]  Sumit K. Chanda,et al.  Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor , 2011, Proceedings of the National Academy of Sciences.

[7]  Rickard Sandberg,et al.  Notch signaling: simplicity in design, versatility in function , 2011, Development.

[8]  S. Ghosh,et al.  Crosstalk in NF-κB signaling pathways , 2011, Nature Immunology.

[9]  Robert J. Lake,et al.  Trp53 regulates Notch 4 signaling through Mdm2 , 2011, Journal of Cell Science.

[10]  Israel Steinfeld,et al.  miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors , 2011, PloS one.

[11]  Yibin Kang,et al.  Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. , 2011, Cancer cell.

[12]  D. J. Jerry,et al.  Repression of Mammary Stem/Progenitor Cells by p53 Is Mediated by Notch and Separable from Apoptotic Activity , 2011, Stem cells.

[13]  A. Mantovani,et al.  Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm , 2010, Nature Immunology.

[14]  A. Levine,et al.  p53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  M. Zenke,et al.  Activated Notch1 Target Genes during Embryonic Cell Differentiation Depend on the Cellular Context and Include Lineage Determinants and Inhibitors , 2010, PloS one.

[16]  U. Lendahl,et al.  Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cells. , 2010, Experimental Cell Research.

[17]  L. R. Perumalsamy,et al.  Notch-activated signaling cascade interacts with mitochondrial remodeling proteins to regulate cell survival , 2010, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Hua Yu,et al.  STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.

[19]  Maija Wolf,et al.  Data integration from two microarray platforms identifies bi-allelic genetic inactivation of RIC8A in a breast cancer cell line , 2009, BMC Medical Genomics.

[20]  Raphael Kopan,et al.  The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism , 2009, Cell.

[21]  D. Johnston,et al.  TNF induction of jagged-1 in endothelial cells is NFkappaB-dependent. , 2009, Gene.

[22]  L. R. Perumalsamy,et al.  A hierarchical cascade activated by non-canonical Notch signaling and the mTOR–Rictor complex regulates neglect-induced death in mammalian cells , 2009, Cell Death and Differentiation.

[23]  L. Strizzi,et al.  Rbpj conditional knockout reveals distinct functions of Notch4/Int3 in mammary gland development and tumorigenesis , 2009, Oncogene.

[24]  U. Lendahl,et al.  Notch-1 associates with IKKα and regulates IKK activity in cervical cancer cells , 2008, Oncogene.

[25]  J. Royds,et al.  Enhanced anti‐cancer effect of a phosphatidylinositol‐3 kinase inhibitor and doxorubicin on human breast epithelial cell lines with different p53 and oestrogen receptor status , 2008, International journal of cancer.

[26]  J. Astola,et al.  Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues , 2008, Genome Biology.

[27]  Yuan Zhang,et al.  Tumor-induced suppressor of cytokine signaling 3 inhibits toll-like receptor 3 signaling in dendritic cells via binding to tyrosine kinase 2. , 2008, Cancer research.

[28]  Chindo Hicks,et al.  Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches. , 2008, Cancer research.

[29]  U. Lendahl,et al.  Notch signaling mediates hypoxia-induced tumor cell migration and invasion , 2008, Proceedings of the National Academy of Sciences.

[30]  D. Santini,et al.  IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. , 2007, The Journal of clinical investigation.

[31]  Karen H. Vousden,et al.  p53 in health and disease , 2007, Nature Reviews Molecular Cell Biology.

[32]  U. Lendahl,et al.  High levels of Notch signaling down-regulate Numb and Numblike , 2006, The Journal of cell biology.

[33]  P. M. Nissom,et al.  A novel normalization method for effective removal of systematic variation in microarray data , 2006, Nucleic acids research.

[34]  R. Clarke,et al.  Aberrant Activation of Notch Signaling in Human Breast Cancer , 2006 .

[35]  U. Lendahl,et al.  Hypoxia requires notch signaling to maintain the undifferentiated cell state. , 2005, Developmental cell.

[36]  L. Holmberg,et al.  Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts , 2005, Breast Cancer Research.

[37]  G. Lockwood,et al.  High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. , 2005, Cancer research.

[38]  P. Hall,et al.  An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Foekens,et al.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.

[40]  James F. Callahan,et al.  Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of IκB Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation , 2005, Journal of Pharmacology and Experimental Therapeutics.

[41]  Patrick Maisonneuve,et al.  Loss of negative regulation by Numb over Notch is relevant to human breast carcinogenesis , 2004, The Journal of cell biology.

[42]  J. Turkson,et al.  STAT proteins as novel targets for cancer drug discovery , 2004, Expert opinion on therapeutic targets.

[43]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[44]  T. Schroeder,et al.  Notch signalling via RBP‐J promotes myeloid differentiation , 2000, The EMBO journal.

[45]  K. Wiman,et al.  Reactivation of Mutant p53 through Interaction of a C-Terminal Peptide with the Core Domain , 1999, Molecular and Cellular Biology.

[46]  G. Haegeman,et al.  p38 and Extracellular Signal-regulated Kinase Mitogen-activated Protein Kinase Pathways Are Required for Nuclear Factor-κB p65 Transactivation Mediated by Tumor Necrosis Factor* , 1998, The Journal of Biological Chemistry.

[47]  T. Honjo,et al.  Site-directed mutagenesis study on DNA binding regions of the mouse homologue of Suppressor of Hairless, RBP-Jx , 1994 .

[48]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[49]  G. Schneider,et al.  NFκB/p53 crosstalk-a promising new therapeutic target. , 2011, Biochimica et biophysica acta.

[50]  S. Blacklow,et al.  Mechanistic insights into Notch receptor signaling from structural and biochemical studies. , 2010, Current topics in developmental biology.

[51]  P. Heitzler.  Biodiversity and noncanonical Notch signaling. , 2010, Current topics in developmental biology.

[52]  T. Golde,et al.  Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. , 2008, Laboratory investigation; a journal of technical methods and pathology.

[53]  T. Golde,et al.  Off the beaten pathway: the complex cross talk between Notch and NF-κB , 2008, Laboratory Investigation.

[54]  Malay Mandal,et al.  Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. , 2007, Nature medicine.

[55]  Malay Mandal,et al.  Targeting the NF-κB signaling pathway in Notch1-induced T-cell leukemia , 2007, Nature Medicine.

[56]  T. Honjo,et al.  Site-directed mutagenesis study on DNA binding regions of the mouse homologue of Suppressor of Hairless, RBP-J kappa. , 1994, Nucleic acids research.